GO	[-5.99 -0.62]	[-0.62 -0.28]	[-0.28 -0.13]	[-0.13 -0.04]	[-0.04 0.00]	[0.00 0.01]	[0.01 0.09]	[0.09 0.19]	[0.19 0.33]	[0.33 0.69]	[0.69 5.49]
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-0.704	-1.382	-0.704	-0.415	-4.964	-5.928	-1.382	1.612	4.473	2.412	3.388
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	-0.442	0.593	-1.132	-2.411	-3.376	-1.681	-1.132	-0.914	0.360	4.149	9.067
ONDER_CDH1_SIGNALING_VIA_CTNNB1 ONDER_CDH1_SIGNALING_VIA_CTNNB1	0.856	2.468	-0.958	-1.836	-1.836	-0.958	-0.958	-3.485	-0.672	1.726	5.414
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	1.851	-1.048	-0.636	-0.482	-3.595	-2.976	-1.318	-1.048	0.756	2.428	5.940
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	0.622	0.622	-0.528	1.104	-4.236	-2.624	-1.278	-2.217	0.293	1.983	5.304
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.606	-0.854	-0.606	-1.592	-0.854	-1.592	-0.854	-1.592	0.324	4.632	6.891
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-2.072	0.445	-1.277	-2.072	-0.282	-2.072	-1.277	-0.552	4.246	1.440	3.838
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-1.659	-0.432	-0.714	-0.432	-2.385	-3.345	-0.714	0.277	1.992	3.489	3.857
WINZEN_DEGRADED_VIA_KHSRP WINZEN_DEGRADED_VIA_KHSRP	-0.733	0.371	-1.006	-2.365	-0.360	-1.006	-2.365	-0.360	0.371	1.438	8.003
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	0.254	0.500	-0.905	-1.186	-1.533	-3.122	-1.957	-0.354	0.661	3.633	4.518
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	0.633	-0.867	-1.327	0.293	-1.615	-4.560	-0.687	0.293	0.389	4.678	2.936
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	0.914	-1.114	-0.714	-0.898	-2.385	-2.385	-0.560	-0.327	-0.327	4.197	4.220
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	1.086	0.870	0.679	-1.164	-3.905	0.515	-1.928	-2.445	0.679	0.376	3.301
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	0.416	0.910	0.416	-1.466	-0.365	0.416	-1.466	-2.280	-0.365	-1.466	6.061
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	1.169	0.509	-1.691	-2.051	-0.545	2.412	-1.382	-2.952	-0.704	1.612	2.731
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	3.050	0.291	-0.443	-1.432	-2.982	0.413	-1.843	-1.432	-0.312	0.936	3.463
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	3.240	0.580	-1.535	-1.926	0.745	0.580	-0.719	-2.395	-2.395	0.745	2.228
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	0.429	0.849	0.326	-1.249	-2.662	-4.420	0.691	-0.806	0.691	1.025	3.427
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	1.679	1.410	0.578	-1.661	-0.761	-1.299	-3.298	-0.566	-1.299	0.945	3.379
HUANG_DASATINIB_SENSITIVITY_UP HUANG_DASATINIB_SENSITIVITY_UP	-1.225	0.353	-1.225	-0.865	-2.363	-2.363	-0.255	0.353	1.902	2.693	2.292
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-2.145	-1.093	-1.384	-1.384	-0.360	0.469	-1.093	-0.652	1.173	3.597	3.616
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	0.435	0.944	-1.431	-0.578	-0.348	-2.239	-1.431	0.258	0.258	-0.578	6.195
ZHANG_INTERFERON_RESPONSE ZHANG_INTERFERON_RESPONSE	-0.994	-0.994	-0.994	-0.994	-0.994	0.426	-0.994	-0.204	0.772	3.048	2.363
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	-0.468	0.721	0.451	0.344	-2.606	-2.178	-1.487	-0.776	-0.354	1.718	5.027
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	0.945	-0.975	-0.337	-0.767	0.268	-0.975	-0.767	-2.715	-0.767	1.354	6.261
NAGASHIMA_EGF_SIGNALING_UP NAGASHIMA_EGF_SIGNALING_UP	0.379	-1.006	-1.006	-1.006	-1.536	-2.363	-0.645	1.900	0.845	0.845	3.352
MOSERLE_IFNA_RESPONSE MOSERLE_IFNA_RESPONSE	-1.326	-1.326	-0.363	-0.702	-0.702	-1.326	0.247	-0.363	0.480	1.647	4.920
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	-0.506	0.962	0.649	-1.011	-2.167	-3.561	-0.814	-0.506	0.519	2.589	2.905
PLASARI_TGFB1_TARGETS_10HR_UP PLASARI_TGFB1_TARGETS_10HR_UP	0.622	-1.045	-0.844	-1.278	-1.860	-2.217	-0.408	-0.528	1.983	2.244	3.465
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	1.638	-0.369	-1.643	-1.643	0.243	0.243	-0.820	-1.643	-1.171	3.755	2.006
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	0.590	0.901	-2.152	-0.595	-0.458	-2.578	-0.761	-1.466	0.590	1.287	4.679
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	0.557	0.995	-1.053	-1.053	-1.053	0.759	-2.658	-1.966	0.390	0.759	4.022
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	2.289	-0.398	-0.790	-1.888	-0.398	1.629	-1.074	-2.466	-0.270	-0.569	3.489
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-0.521	-0.293	-0.395	-2.001	-1.081	-1.081	-0.395	-1.341	0.675	1.431	6.321
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	0.945	-1.003	0.432	0.578	-2.637	-2.637	-1.003	-0.761	0.432	2.286	2.637
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	1.205	1.546	-1.783	-0.329	-0.810	-0.810	-1.211	-1.211	-0.527	-0.329	5.008
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.884	0.310	-0.292	-2.256	-2.256	-0.541	-2.256	-0.541	1.081	2.081	2.718
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	-1.171	-0.369	-0.820	-0.820	-1.171	-2.290	0.772	0.243	-0.369	2.813	3.769
SAGIV_CD24_TARGETS_DN SAGIV_CD24_TARGETS_DN	-1.865	-1.124	-1.124	-1.124	0.226	-1.124	0.226	0.226	1.320	1.736	3.298
FRASOR_RESPONSE_TO_ESTRADIOL_DN FRASOR_RESPONSE_TO_ESTRADIOL_DN	0.243	1.024	-1.171	-0.369	0.243	-3.236	-0.820	-0.820	-0.559	1.638	3.769
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	0.944	1.321	-1.028	-1.028	0.301	-4.911	-1.260	-0.302	1.535	0.396	2.027
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	-0.399	2.820	0.587	-1.536	-0.399	-0.235	-1.536	-2.363	-0.399	-0.235	2.830
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	0.547	2.520	-0.845	-1.623	-0.285	-2.386	-1.321	-1.063	-0.285	1.456	2.848
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	0.721	0.721	-1.612	-0.562	-0.712	-0.562	-1.095	-0.889	-1.929	3.006	3.673
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	1.190	-0.382	-2.322	-0.382	-0.622	1.551	-0.977	-1.501	-0.977	0.877	2.906
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	-2.031	0.334	-0.271	-0.472	-2.031	-1.259	-0.271	-0.472	1.938	1.137	2.419
KRASNOSELSKAYA_ILF3_TARGETS_UP KRASNOSELSKAYA_ILF3_TARGETS_UP	-1.658	-0.958	-0.300	-0.958	-1.658	0.527	-0.549	0.302	0.302	2.069	3.191
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-0.691	-0.434	-1.606	-1.064	0.784	-0.260	-1.606	-1.064	0.784	1.075	4.305
BOWIE_RESPONSE_TO_TAMOXIFEN BOWIE_RESPONSE_TO_TAMOXIFEN	-0.746	-0.746	-0.746	-0.746	-0.298	-0.746	-0.746	0.655	0.304	1.128	4.066
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	0.892	0.736	-2.266	-1.078	-1.591	-0.427	-0.551	-1.316	0.278	1.926	3.716
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	1.503	1.503	-0.645	-2.363	-0.399	-1.536	0.379	-0.399	-1.006	-0.399	2.830
PHONG_TNF_TARGETS_UP PHONG_TNF_TARGETS_UP	-0.786	-1.181	-0.315	-1.181	-0.508	-1.748	-0.508	-0.315	2.411	0.675	3.933
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	-1.119	-0.550	0.644	-0.260	-1.119	-1.119	-1.119	-0.260	1.032	0.644	3.376
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	1.086	0.679	-0.343	-2.445	-0.661	-0.343	-1.508	-1.928	0.515	0.679	3.707
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	-0.327	-1.091	-2.180	-0.327	0.276	-1.091	-0.506	-0.753	0.850	0.850	5.108
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	0.660	0.660	-1.362	-2.440	0.522	0.660	-2.440	-1.362	0.402	1.639	2.175
LEE_LIVER_CANCER_SURVIVAL_UP LEE_LIVER_CANCER_SURVIVAL_UP	0.914	2.258	-0.327	-0.898	-0.560	-1.367	-0.432	-0.898	-2.831	0.606	3.177
CROMER_TUMORIGENESIS_UP CROMER_TUMORIGENESIS_UP	-0.247	-1.571	-0.416	-0.668	-0.247	-0.416	-1.571	-1.035	0.362	1.844	4.405
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	0.937	-0.412	-1.739	-1.253	0.339	-0.266	-1.253	-1.253	0.339	0.701	4.571
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	1.988	-0.711	-0.489	0.278	-1.901	-0.711	-1.901	0.278	-0.489	0.595	3.680
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.390	-0.390	-0.606	-0.910	-0.910	-1.927	-1.332	0.372	1.062	2.119	3.020
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	-0.512	-0.512	0.782	-0.373	-1.487	-2.896	-0.903	-0.512	0.976	1.984	2.634
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	-0.934	1.439	0.467	-0.289	-2.473	-1.803	-0.934	0.467	0.657	-0.289	2.959
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	-1.160	-0.280	0.324	-1.160	-1.160	-0.280	-0.580	-0.280	-0.280	1.962	3.244
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	0.632	-0.290	0.456	0.456	-0.875	-2.882	-2.164	-0.432	0.632	0.456	3.164
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	0.331	-0.388	-1.254	-0.538	-0.538	-2.573	-0.963	-0.388	1.470	1.218	3.485
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	-0.704	-0.704	-0.704	-0.704	-0.272	-0.704	-0.704	0.332	1.206	1.206	2.547
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	0.536	-0.430	-0.580	-2.485	-0.580	2.414	-0.996	-0.996	-0.767	1.298	2.428
MIKKELSEN_ES_ICP_WITH_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K27ME3	1.477	-0.336	0.749	-1.024	-0.599	0.476	-1.741	-1.741	-0.336	0.269	2.440
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	-1.424	1.592	-0.276	-0.986	-0.986	-2.035	0.328	-0.668	0.499	1.259	2.377
ISSAEVA_MLL2_TARGETS ISSAEVA_MLL2_TARGETS	-1.122	1.325	-0.287	-0.738	-0.738	-0.470	0.315	-1.677	-0.738	0.728	4.114
GILDEA_METASTASIS GILDEA_METASTASIS	-1.202	-0.300	0.302	0.572	-1.202	-0.300	-0.300	-1.202	-0.610	1.877	2.467
SU_PLACENTA SU_PLACENTA	-1.284	-0.341	0.264	-0.671	-0.671	0.836	-1.284	0.836	0.264	-0.671	3.562
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	-1.243	-0.320	-1.243	-1.243	0.283	-0.320	-0.640	0.539	0.880	0.539	3.000
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	1.459	0.643	-1.054	-3.159	-0.623	-1.054	-0.623	-0.465	0.643	1.222	2.010
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	1.507	-0.634	-0.366	-1.027	-0.634	2.014	-0.634	-1.578	-1.027	-0.486	3.262
HAN_JNK_SINGALING_UP HAN_JNK_SINGALING_UP	-0.796	-0.796	-1.450	0.403	-0.796	-0.430	-0.796	2.478	-0.219	0.403	2.486
FARMER_BREAST_CANCER_CLUSTER_1 FARMER_BREAST_CANCER_CLUSTER_1	0.848	0.571	-0.755	-1.990	-0.256	0.351	-1.990	-0.755	0.351	0.848	2.009
WILCOX_RESPONSE_TO_PROGESTERONE_DN WILCOX_RESPONSE_TO_PROGESTERONE_DN	-0.835	-0.344	0.262	0.262	-2.696	-0.344	-1.241	0.627	0.876	0.262	3.238
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	0.578	1.055	-0.355	-1.612	-2.253	-1.144	-0.541	0.396	-0.355	0.798	2.888
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	0.426	-0.462	-0.204	-0.994	-0.994	-0.462	-0.994	0.426	-0.462	0.772	3.822
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	1.242	0.564	-0.791	-0.270	-0.479	-0.270	-1.830	-1.830	-0.993	0.866	3.470
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-0.434	0.541	-1.606	-1.064	0.784	1.075	-1.606	-0.260	-0.691	-0.260	3.189
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	-1.832	0.310	-0.712	0.708	-2.256	-1.474	0.310	0.884	1.081	0.421	2.396
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	-0.301	2.892	-0.301	0.301	-1.514	-0.849	-1.143	-0.849	-0.617	0.301	2.906
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	0.823	-0.621	-0.621	-0.621	-0.621	-0.621	-0.621	-0.223	0.396	0.823	2.871
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	-0.272	-0.552	-0.552	-1.334	0.816	0.467	-2.225	-0.756	1.032	-0.393	3.692
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	-0.278	0.484	-0.633	-1.280	-0.427	-0.911	-1.771	0.484	1.176	-0.427	3.971
TAVOR_CEBPA_TARGETS_DN TAVOR_CEBPA_TARGETS_DN	-1.326	0.247	0.247	-0.702	-0.702	-1.326	0.247	-0.702	1.647	0.793	2.184
SANA_RESPONSE_TO_IFNG_UP SANA_RESPONSE_TO_IFNG_UP	-0.488	-1.064	-0.488	-0.732	-1.517	-1.064	0.288	0.445	0.288	3.071	2.210
HINATA_NFKB_TARGETS_KERATINOCYTE_UP HINATA_NFKB_TARGETS_KERATINOCYTE_UP	0.289	-0.691	0.289	-1.868	-0.473	-0.981	0.435	-0.691	-0.691	2.034	3.281
AMIT_SERUM_RESPONSE_60_MCF10A AMIT_SERUM_RESPONSE_60_MCF10A	-0.668	-0.247	-0.416	-0.247	-1.571	-1.571	-0.668	-0.416	1.844	0.814	2.757
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	1.246	1.007	0.322	-0.774	-2.878	-0.774	-1.034	0.452	0.322	-0.567	2.469
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	-0.904	0.859	-0.343	-0.904	-1.952	0.859	-1.112	-1.354	0.859	1.214	2.405
LIU_SMARCA4_TARGETS LIU_SMARCA4_TARGETS	1.461	0.521	-1.294	0.521	0.521	-0.810	-1.294	-0.810	-0.810	-0.492	2.857
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	0.536	0.872	0.291	0.291	-2.007	-1.274	-1.274	-0.580	-0.767	2.103	2.116
BECKER_TAMOXIFEN_RESISTANCE_DN BECKER_TAMOXIFEN_RESISTANCE_DN	0.664	-0.578	-0.921	-0.921	-1.431	-0.578	0.258	2.076	-0.921	0.435	2.553
RAY_ALZHEIMERS_DISEASE RAY_ALZHEIMERS_DISEASE	-0.176	-0.538	-0.176	-0.538	-0.538	0.967	-0.538	0.476	-0.538	-0.538	3.267
SENESE_HDAC2_TARGETS_DN SENESE_HDAC2_TARGETS_DN	0.372	2.411	-1.104	0.264	-0.641	0.264	-1.104	-1.104	-1.416	0.660	2.425
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP	-0.497	0.166	0.166	-0.497	0.166	-0.497	-0.497	-0.497	1.731	-0.497	2.552
